Insider Trading activities of Sangamo Therapeutics, Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sangamo Therapeutics, Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sangamo Therapeutics, Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Sangamo Therapeutics, Inc since 2005. The reporting company's ticker symbol is SGMO. The reporting company's CIK number is 1001233.
The total value of stock buying since 2005 is $56,766,011.
The total value of stock sales since 2005 is $143,864,550.
The total value of stock option exercises since 2005 is $11,848,841.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Sangamo Therapeutics, Inc insiders (SGMO) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-08-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 13,202 4.11 54,260
2014-08-04 Larson John William (Director) Sale 10,000 12.56 125,580
2014-08-04 Larson John William (Director) Option Ex 10,000 4.00 40,000
2014-08-01 Kolchinsky Peter Sale 27,770 12.82 356,094
2014-08-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 12.54 188,145
2014-08-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 5.21 78,105
2014-07-30 Kolchinsky Peter Sale 109,590 12.44 1,362,751
2014-07-29 Kolchinsky Peter Sale 1,407 12.41 17,463
2014-07-28 Kolchinsky Peter Sale 60,081 12.11 727,400
2014-07-25 Kolchinsky Peter Sale 47,429 12.31 583,945
2014-07-24 Kolchinsky Peter Sale 124,050 12.28 1,523,209
2014-07-18 Lanphier Edward O Ii (President & CEO) Sale 25,000 12.16 303,950
2014-07-18 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 4.11 102,750
2014-07-17 Kolchinsky Peter Buy 37,215 12.26 456,218
2014-07-10 Wolff Henry Ward (Exec VP & CFO) Sale 15,000 13.23 198,435
2014-07-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 13,000 7.50 97,565
2014-07-01 Kolchinsky Peter Sale 82,700 16.00 1,323,282
2014-07-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 15.66 234,870
2014-07-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 5.21 78,105
2014-06-23 Ramasastry Saira (Director) Sale 5,550 15.54 86,219
2014-06-23 Ramasastry Saira (Director) Option Ex 5,550 5.03 27,916
2014-06-16 Kolchinsky Peter Sale 250,500 16.50 4,132,999
2014-06-16 Lanphier Edward O Ii (President & CEO) Sale 25,000 16.41 410,149
2014-06-10 Wolff Henry Ward (Exec VP & CFO) Sale 15,000 15.62 234,360
2014-06-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 13,000 7.73 100,490
2014-06-09 Kolchinsky Peter Sale 83,500 15.50 1,294,166
2014-06-09 Mento Steven J (Director) Sale 4,328 15.00 64,920
2014-06-09 Mento Steven J (Director) Option Ex 5,834 7.28 42,471
2014-06-06 Kolchinsky Peter Sale 135,101 14.20 1,918,569
2014-06-05 Kolchinsky Peter Sale 1,085,463 13.84 14,779,008
2014-06-04 Kolchinsky Peter Sale 70,640 13.10 925,172
2014-06-03 Kolchinsky Peter Sale 76,833 12.86 988,072
2014-06-02 Gregory Philip D (SVP of Research & CSO) Sale 15,000 12.85 192,720
2014-06-02 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 5.21 78,105
2014-05-30 Kolchinsky Peter Sale 65,884 13.41 883,702
2014-05-29 Kolchinsky Peter Sale 155,675 13.52 2,105,193
2014-05-28 Kolchinsky Peter Sale 148,689 13.45 1,999,569
2014-05-27 Kolchinsky Peter Sale 263,437 13.55 3,570,625
2014-05-27 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 13.57 203,520
2014-05-27 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 4.32 64,800
2014-05-23 Kolchinsky Peter Sale 51,597 13.27 684,692
2014-05-22 Kolchinsky Peter Sale 56,396 13.54 763,714
2014-05-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 13.14 328,550
2014-05-13 Kolchinsky Peter Sale 56,060 13.12 735,282
2014-05-12 Kolchinsky Peter Sale 29,659 13.03 386,545
2014-05-12 Wolff Henry Ward (Exec VP & CFO) Sale 15,000 12.85 192,735
2014-05-12 Wolff Henry Ward (Exec VP & CFO) Option Ex 13,000 7.73 100,490
2014-05-08 Kolchinsky Peter Sale 83,300 12.39 1,032,420
2014-05-07 Kolchinsky Peter Buy 83,300 11.90 989,461
2014-05-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 13.68 205,185
2014-05-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 5.21 78,105
2014-04-30 Kolchinsky Peter Buy 124,500 13.43 1,671,537
2014-04-28 Kolchinsky Peter Buy 74,844 13.29 995,050
2014-04-28 Larson John William (Director) Sale 10,000 13.48 134,790
2014-04-28 Larson John William (Director) Option Ex 10,000 5.66 56,600
2014-04-28 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 13.63 204,480
2014-04-28 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 4.32 64,800
2014-04-25 Kolchinsky Peter Buy 166,000 13.63 2,262,746
2014-04-22 Kolchinsky Peter Sale 352,750 14.86 5,243,276
2014-04-17 Kolchinsky Peter Buy 41,500 14.02 581,954
2014-04-16 Kolchinsky Peter Sale 21,829 14.09 307,657
2014-04-15 Kolchinsky Peter Buy 21,829 13.13 286,614
2014-04-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 14.20 355,025
2014-04-14 Kolchinsky Peter Sale 3,055 14.78 45,165
2014-04-11 Kolchinsky Peter Buy 116,992 14.48 1,694,512
2014-04-10 Kolchinsky Peter Buy 83,000 14.91 1,237,364
2014-04-10 Kolchinsky Peter Sale 3,403 15.67 53,325
2014-04-10 Wolff Henry Ward (Exec VP & CFO) Sale 15,000 15.73 235,920
2014-04-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 13,000 7.73 100,490
2014-04-09 Kolchinsky Peter Sale 69,856 16.27 1,136,417
2014-04-08 Kolchinsky Peter Buy 121,876 15.49 1,888,224
2014-04-07 Kolchinsky Peter Buy 33,667 15.43 519,313
2014-04-04 Kolchinsky Peter Buy 179,031 15.38 2,753,675
2014-04-03 Kolchinsky Peter Buy 195,126 16.61 3,242,018
2014-04-01 Kolchinsky Peter Sale 250,000 17.98 4,495,750
2014-04-01 Gregory Philip D (Sr. VP Res. & CSO) Sale 15,000 17.80 267,000
2014-04-01 Gregory Philip D (Sr. VP Res. & CSO) Option Ex 15,000 7.40 111,000
2014-03-28 Kolchinsky Peter Buy 84,000 17.09 1,435,392
2014-03-27 Kolchinsky Peter Buy 256,187 17.50 4,484,297
2014-03-26 Kolchinsky Peter Buy 210,013 18.02 3,784,224
2014-03-25 Kolchinsky Peter Buy 84,000 19.41 1,630,356
2014-03-21 Kolchinsky Peter Buy 101,808 21.22 2,159,958
2014-03-21 Gregory Philip D (See Remarks) Sale 15,000 22.38 335,760
2014-03-21 Gregory Philip D (See Remarks) Option Ex 15,000 6.74 101,130
2014-03-19 Kolchinsky Peter Sale 17,808 24.28 432,431
2014-03-18 Kolchinsky Peter Sale 84,000 23.75 1,994,580
2014-03-17 Ramasastry Saira (Director) Sale 10,000 23.26 232,610
2014-03-17 Ramasastry Saira (Director) Option Ex 10,000 5.03 50,300
2014-03-17 Kolchinsky Peter Buy 52,161 23.02 1,200,850
2014-03-17 Lanphier Edward O Ii (President & CEO) Sale 50,000 23.22 1,160,950
2014-03-17 Lanphier Edward O Ii (President & CEO) Option Ex 50,000 5.19 259,500
2014-03-14 Mento Steven J (Director) Sale 6,103 22.77 138,953
2014-03-14 Mento Steven J (Director) Option Ex 9,722 3.87 37,624
2014-03-13 Kolchinsky Peter Buy 71,319 22.76 1,623,363
2014-03-12 Kolchinsky Peter Sale 123,480 23.40 2,889,432
2014-03-10 Kolchinsky Peter Buy 12,522 22.30 279,177
2014-03-10 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 22.31 223,070
2014-03-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2014-03-07 Kolchinsky Peter Buy 258,377 22.25 5,748,629
2014-03-06 Kolchinsky Peter Buy 84,001 22.50 1,890,274
2014-03-06 Kolchinsky Peter Sale 354,900 23.79 8,368,700
2014-03-03 Kolchinsky Peter Sale 84,000 18.22 1,530,312
2014-02-28 Kolchinsky Peter Buy 42,000 18.10 760,158
2014-02-27 Kolchinsky Peter Sale 32,196 19.36 623,282
2014-02-26 Kolchinsky Peter Buy 74,194 19.52 1,448,563
2014-02-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 19.72 295,815
2014-02-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 4.32 64,800
2014-02-20 Kolchinsky Peter Sale 35,319 18.39 649,693
2014-02-19 Kolchinsky Peter Sale 6,720 18.52 124,420
2014-02-18 Kolchinsky Peter Sale 11,172 18.11 202,280
2014-02-18 Lanphier Edward O Ii (President & CEO) Sale 50,000 18.09 904,350
2014-02-18 Lanphier Edward O Ii (President & CEO) Option Ex 50,000 5.19 259,500
2014-02-14 Kolchinsky Peter Sale 15,380 18.61 286,160
2014-02-14 Ringo William R (Director) Sale 25,000 18.06 451,574
2014-02-14 Ringo William R (Director) Option Ex 25,000 5.54 138,500
2014-02-13 Kolchinsky Peter Sale 15,409 18.46 284,434
2014-02-12 Kolchinsky Peter Buy 42,000 18.04 757,638
2014-02-11 Kolchinsky Peter Buy 42,000 19.65 825,258
2014-02-10 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 19.26 192,640
2014-02-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2014-02-07 Kolchinsky Peter Sale 34,688 18.52 642,421
2014-02-06 Kolchinsky Peter Sale 7,312 18.42 134,679
2014-02-05 Kolchinsky Peter Buy 42,000 18.25 766,332
2014-02-03 Gregory Philip D (Vice President, Research & CSO) Sale 15,000 18.83 282,510
2014-02-03 Gregory Philip D (Vice President, Research & CSO) Option Ex 15,000 3.78 56,700
2014-01-27 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 18.64 279,645
2014-01-27 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 4.32 64,800
2014-01-15 Cleveland Paul B (Director) Sale 8,333 18.68 155,693
2014-01-15 Cleveland Paul B (Director) Option Ex 8,333 5.03 41,914
2014-01-15 Lanphier Edward O Ii (President & CEO) Sale 50,000 18.51 925,700
2014-01-15 Lanphier Edward O Ii (President & CEO) Option Ex 50,000 6.39 319,500
2014-01-10 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 18.69 186,890
2014-01-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2014-01-09 Kolchinsky Peter Sale 72,440 18.37 1,331,012
2014-01-02 Gregory Philip D (Vice President, Research & CSO) Sale 15,000 13.56 203,340
2014-01-02 Gregory Philip D (Vice President, Research & CSO) Option Ex 15,000 3.78 56,700
2013-12-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 14.30 214,575
2013-12-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 4.32 64,800
2013-12-18 Lanphier Edward O Ii (President & CEO) Sale 50,000 12.47 623,700
2013-12-18 Lanphier Edward O Ii (President & CEO) Option Ex 50,000 6.39 319,500
2013-12-13 Kolchinsky Peter Buy 5,040 12.09 60,923
2013-12-12 Kolchinsky Peter Buy 9,600 12.09 116,073
2013-12-10 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 11.97 119,670
2013-12-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2013-12-02 Cleveland Paul B (Director) Sale 10,000 11.64 116,390
2013-12-02 Cleveland Paul B (Director) Option Ex 10,000 6.41 64,100
2013-12-02 Gregory Philip D (Vice President, Research & CSO) Sale 15,000 11.66 174,840
2013-12-02 Gregory Philip D (Vice President, Research & CSO) Option Ex 15,000 3.78 56,700
2013-11-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 11.82 177,375
2013-11-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 4.08 61,245
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of SGMO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sangamo Therapeutics, Inc (symbol SGMO, CIK number 1001233) see the Securities and Exchange Commission (SEC) website.